Cost-Utility Analysis of Long-Acting Paliperidone in Comparison with Oral Risperidone, Oral Paliperidone and Long-Acting Risperidone in the Maintenance Treatment of Schizophrenia in the Czech Republic.

MLA

Kolek, M., et al. “Cost-Utility Analysis of Long-Acting Paliperidone in Comparison with Oral Risperidone, Oral Paliperidone and Long-Acting Risperidone in the Maintenance Treatment of Schizophrenia in the Czech Republic.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 17, no. 7, Nov. 2014, p. A459. EBSCOhost, https://doi.org/10.1016/j.jval.2014.08.1266.

APA

Kolek, M., Duba, J., Vesela, S., Pasztor, B., & Doleckova, J. (2014). Cost-Utility Analysis of Long-Acting Paliperidone in Comparison with Oral Risperidone, Oral Paliperidone and Long-Acting Risperidone in the Maintenance Treatment of Schizophrenia in the Czech Republic. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A459. https://doi.org/10.1016/j.jval.2014.08.1266

Chicago

Kolek, M, J Duba, S Vesela, B Pasztor, and J Doleckova. 2014. “Cost-Utility Analysis of Long-Acting Paliperidone in Comparison with Oral Risperidone, Oral Paliperidone and Long-Acting Risperidone in the Maintenance Treatment of Schizophrenia in the Czech Republic.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 17 (7): A459. doi:10.1016/j.jval.2014.08.1266.